Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 19186618 | GERMACRENE SYNTHASE SgTPS7 PROTEIN, CODING GENE AND USE IN SYNTHESIS OF GERMACRENE | April 2025 | November 2025 | Allow | 7 | 1 | 0 | Yes | No |
| 18933327 | CARBONYL REDUCTASE MUTANT AND ITS APPLICATION | October 2024 | March 2025 | Allow | 5 | 1 | 0 | No | No |
| 18859487 | ALDITOL OXIDASE AND APPLICATION THEREOF | October 2024 | February 2025 | Allow | 4 | 0 | 0 | No | No |
| 18846061 | ENZYMATIC METHOD FOR THE PRODUCTION OF L-GLUFOSINATE P-ESTERS | September 2024 | June 2025 | Allow | 9 | 1 | 0 | Yes | No |
| 18825195 | GENETIC ENGINEERING BACTERIUM FOR DE NOVO SYNTHESIS OF CIS,CIS-MUCONIC ACID BY TAKING GLUCOSE AS SUBSTRATE AND APPLICATIONS THEREOF | September 2024 | April 2025 | Allow | 8 | 2 | 0 | Yes | No |
| 18658938 | CPF1 PROTEIN AND ITS USE IN GENE EDITING | May 2024 | February 2025 | Allow | 9 | 1 | 0 | No | No |
| 18595947 | Methods Of Producing Omega-Hydroxylated Fatty Acid Derivatives | March 2024 | December 2025 | Allow | 21 | 2 | 0 | No | No |
| 18420028 | ESCHERICHIA COLI FOR SYNTHESIZING L-VALINE, CONSTRUCTION METHOD AND USE THEREOF | January 2024 | July 2025 | Allow | 18 | 1 | 0 | Yes | No |
| 18413338 | ENGINEERED ADENYLATE KINASE VARIANT ENZYMES | January 2024 | February 2026 | Abandon | 25 | 1 | 1 | No | No |
| 18393317 | METHANE MONOOXYGENASE ENZYMES | December 2023 | March 2025 | Allow | 15 | 1 | 1 | No | No |
| 18390570 | MICROORGANISMS AND METHODS FOR IMPROVING PRODUCT YIELDS ON METHANOL USING ACETYL-COA SYNTHESIS | December 2023 | September 2025 | Allow | 21 | 2 | 1 | No | No |
| 18544037 | PROCESS FOR ETHANOL PRODUCTION | December 2023 | March 2026 | Abandon | 27 | 2 | 0 | No | No |
| 18542109 | GLUTAMATE DECARBOXYLASE MUTANT WITH IMPROVED PH TOLERANCE AND USE THEREOF IN SYNTHESIS OF GAMMA-AMINOBUTYRIC ACID | December 2023 | August 2025 | Allow | 20 | 1 | 0 | No | No |
| 18533016 | ENGINEERED BETA-SUBUNIT OF TRYPTOPHAN SYNTHASE FOR PRODUCTION OF NON-CANONICAL AMINO ACIDS | December 2023 | September 2025 | Allow | 21 | 2 | 1 | Yes | No |
| 18503526 | BETA-GALACTOSIDASE ENZYMES | November 2023 | April 2025 | Allow | 17 | 1 | 0 | Yes | No |
| 18351633 | TREATMENT OF RETINITIS PIGMENTOSA USING ENGINEERED MEGANUCLEASES | July 2023 | April 2025 | Abandon | 21 | 1 | 0 | No | No |
| 18344219 | PRODUCTION OF FATTY ACID DERIVATIVES | June 2023 | February 2026 | Allow | 32 | 2 | 1 | Yes | No |
| 18329971 | Animal Feed Additives Comprising a Polypeptide having Protease Activity and Uses Thereof | June 2023 | February 2026 | Allow | 32 | 4 | 1 | Yes | No |
| 18330340 | PROCESSES FOR PRODUCTION OF ALKYLATED FATTY ACIDS AND DERIVATIVES THEREOF | June 2023 | July 2025 | Abandon | 25 | 1 | 1 | No | No |
| 17640807 | RECOMBINANT ESCHERICHIA COLI FOR PRODUCING GLUTARATE, CONSTRUCTION METHOD AND USE THEREOF | June 2023 | July 2025 | Allow | 40 | 1 | 0 | Yes | No |
| 18327386 | GH30 in Wet Milling | June 2023 | November 2025 | Allow | 29 | 1 | 0 | No | No |
| 18325714 | CHIMERIC ALKALINE PHOSPHATASE-LIKE PROTEINS | May 2023 | September 2025 | Allow | 28 | 1 | 1 | No | No |
| 18319444 | RECOMBINANT BACTERIAL CELLS AND METHODS FOR PRODUCING POLY(3-HYDROXYBUTYRATE-CO-3-HYDROXYVALERATE) | May 2023 | November 2023 | Allow | 6 | 0 | 1 | No | No |
| 18319442 | RECOMBINANT BACTERIAL CELLS AND METHODS FOR PRODUCING POLY(3-HYDROXYBUTYRATE-CO-3-HYDROXYVALERATE) | May 2023 | March 2024 | Allow | 10 | 1 | 1 | No | No |
| 18034449 | Method for the Production of Thiocarbamate Derivatives A2AR Inhibitors | April 2023 | March 2026 | Abandon | 35 | 0 | 1 | No | No |
| 18302911 | METHOD OF PRODUCING CALCIUM PROPIONATE BY USING LACTOBACILLUS REUTERI | April 2023 | November 2023 | Allow | 7 | 1 | 0 | No | No |
| 18031545 | Engineered microorganisms expressing acetoacetyl-CoA reductase variants and method for improving the yield of PHA | April 2023 | October 2023 | Allow | 7 | 1 | 0 | Yes | No |
| 18132027 | Recombinant Production of Steviol Glycosides | April 2023 | May 2025 | Allow | 25 | 1 | 0 | Yes | No |
| 18188043 | PROCESS FOR MAKING RECOMBINANT ANTIDOTE TO FACTOR XA INHIBITOR | March 2023 | December 2024 | Abandon | 21 | 1 | 0 | No | No |
| 18121226 | High Purity Protein Preparation from Plant Material and Products Thereof | March 2023 | December 2025 | Abandon | 34 | 5 | 0 | No | No |
| 18043258 | FLAVIN-DEPENDENT OXIDASES HAVING CANNABINOID SYNTHASE ACTIVITY | February 2023 | December 2025 | Abandon | 34 | 0 | 1 | No | No |
| 18172594 | MICROBIAL PRODUCTION OF ROTUNDONE | February 2023 | September 2024 | Allow | 19 | 1 | 1 | No | No |
| 18166707 | PROTEASE VARIANTS AND USES THEREOF | February 2023 | February 2026 | Abandon | 36 | 2 | 0 | No | No |
| 18164522 | BIOCATALYSTS AND METHODS FOR THE SYNTHESIS OF SUBSTITUTED LACTAMS | February 2023 | August 2024 | Allow | 18 | 1 | 1 | No | No |
| 18006310 | ENZYMES AND METHODS FOR PRODUCTION OF MALONIC ACID AND DERIVATIVES THEREOF | January 2023 | February 2026 | Abandon | 36 | 0 | 1 | No | No |
| 18006316 | ENZYMES AND METHODS FOR PRODUCTION OF MALONIC ACID AND DERIVATIVES THEREOF | January 2023 | March 2026 | Abandon | 38 | 1 | 0 | No | No |
| 18005079 | USE OF UV-ACTIVATED ENZYMES TO IMPLEMENT OXIDATION REACTIONS AND THE CORRESPONDING PROCESSES | January 2023 | February 2026 | Abandon | 37 | 0 | 1 | No | No |
| 18004364 | METHOD FOR THE FERMENTATIVE PRODUCTION OF GUANIDINOACETIC ACID | January 2023 | February 2024 | Allow | 13 | 2 | 1 | Yes | No |
| 18149872 | YEAST PROMOTORS FOR PROTEIN EXPRESSION | January 2023 | November 2024 | Allow | 23 | 2 | 1 | No | No |
| 18146661 | METHODS AND COMPOSITIONS INVOLVING PROMOTERS DERIVED FROM YARROWIA LIPOLYTICA | December 2022 | February 2025 | Abandon | 26 | 2 | 0 | No | No |
| 18145073 | ESTERASES AND USES THEREOF | December 2022 | November 2023 | Allow | 10 | 1 | 0 | No | No |
| 17927023 | PHYTASE MUTANT | November 2022 | February 2026 | Allow | 39 | 2 | 1 | No | No |
| 18056728 | DEHYDROGENASE MUTANT L283V/L286V, AND PREPARATION METHOD AND USE THEREOF | November 2022 | September 2023 | Allow | 10 | 1 | 0 | Yes | No |
| 17926487 | CELLS AND METHODS FOR PRODUCING METHYL KETONES | November 2022 | January 2026 | Allow | 38 | 2 | 0 | No | No |
| 17998217 | METHOD FOR PREPARING PYRROLIDONE | November 2022 | October 2024 | Abandon | 23 | 2 | 0 | No | No |
| 17961625 | BETA-GALACTOSIDASE ENZYMES | October 2022 | August 2023 | Allow | 11 | 1 | 0 | No | No |
| 17917549 | ENGINEERED BIOSYNTHETIC PATHWAYS FOR PRODUCTION OF ECTOINE BY FERMENTATION | October 2022 | December 2025 | Abandon | 39 | 1 | 0 | No | No |
| 17910787 | METHOD FOR PREPARING L-GLUFOSINATE AMMONIUM BY BIOLOGICAL ENZYMATIC DE-RACEMIZATION, GLUFOSINATE AMMONIUM DEHYDROGENASE MUTANT AND USE THEREOF | September 2022 | September 2025 | Allow | 36 | 2 | 0 | No | No |
| 17823853 | COFACTOR SELF-SUFFICIENT ESCHERICHIA COLI AND CONSTRUCTION METHOD AND APPLICATION THEREOF | August 2022 | June 2024 | Allow | 22 | 1 | 0 | Yes | No |
| 17823471 | MICROBIAL FERMENTATION FOR THE PRODUCTION OF TERPENES | August 2022 | January 2025 | Allow | 29 | 3 | 0 | No | No |
| 17908059 | GENETICALLY MODIFIED MICROORGANISM FOR PRODUCING 3-HYDROXYHEXANEDIOIC ACID AND/OR (E)-HEX-2-ENEDIOIC ACID AND PRODUCTION METHOD FOR SAID CHEMICALS | August 2022 | January 2026 | Allow | 40 | 1 | 0 | No | No |
| 17823034 | OLEIC ACID PRODUCED FROM MICROORGANISM AND METHOD FOR PRODUCING OLEIC ACID USING MICROORGANISM | August 2022 | May 2025 | Abandon | 33 | 4 | 0 | No | No |
| 17821404 | MICROBIAL FERMENTATION FOR THE PRODUCTION OF ISOPRENOID ALCOHOLS AND DERIVATIVES | August 2022 | September 2024 | Abandon | 32 | 1 | 1 | No | No |
| 17800898 | METHODS AND SYSTEMS FOR LACTIC ACID PRODUCTION AND POLYLACTIC ACID RECYCLING | August 2022 | February 2026 | Allow | 42 | 1 | 1 | No | No |
| 17819065 | NPP1 FUSION PROTEINS | August 2022 | May 2025 | Abandon | 34 | 2 | 1 | No | No |
| 17883115 | BACTERIAL N-DEMTHYLASES AS BIOCATALYSTS FOR THE PRODUCTION OF METHYLXANTHINES | August 2022 | July 2025 | Allow | 36 | 4 | 1 | No | No |
| 17816586 | METHOD FOR PRODUCING VANILLIN | August 2022 | November 2024 | Allow | 28 | 3 | 0 | Yes | No |
| 17878040 | ALKALINE PROTEASE MUTANT, AND GENE, ENGINEERED STRAIN, PREPARATION METHOD AND APPLICATION THEREOF | July 2022 | January 2023 | Allow | 5 | 0 | 0 | Yes | No |
| 17858801 | Variants of Family a Dna Polymerase and Uses Thereof | July 2022 | November 2024 | Allow | 28 | 3 | 1 | Yes | No |
| 17790787 | Use of Biological Enzyme for Preparing Orlistat Intermediate, and Preparation Method | July 2022 | August 2025 | Allow | 37 | 1 | 0 | No | No |
| 17838078 | DNA POLYMERASES | June 2022 | August 2024 | Abandon | 27 | 2 | 0 | No | No |
| 17784304 | GENETICALLY ENGINEERED MICROORGANISM CAPABLE OF GROWING ON FORMATE, METHANOL, METHANE OR CO2 | June 2022 | December 2025 | Allow | 42 | 1 | 0 | Yes | No |
| 17836566 | METHOD FOR INCREASING THE PRODUCTION OF SMALL MOLECULES IN SUBMERGED CORYNEBACTERIUM CULTURE | June 2022 | April 2025 | Allow | 34 | 2 | 0 | No | No |
| 17806138 | BIOLOGICAL DEVICES AND METHODS OF USE THEREOF TO PRODUCE STEVIOL GLYCOSIDES | June 2022 | March 2026 | Allow | 45 | 3 | 1 | No | No |
| 17830420 | Method for Producing D-psicose | June 2022 | July 2023 | Allow | 14 | 1 | 0 | Yes | No |
| 17780423 | METHOD FOR PRODUCING HETEROGENOUS CANNABICHROMENE FROM SACCHAROMYCES CEREVISIAE | May 2022 | December 2025 | Abandon | 42 | 1 | 1 | No | No |
| 17751277 | Compositions and Methods for Producing High Secreted Yields of Recombinant Proteins | May 2022 | June 2024 | Allow | 25 | 1 | 1 | No | No |
| 17750293 | METHOD FOR THE IN VIVO SYNTHESIS OF 4-HYDROXYMETHYLFURFURAL AND DERIVATIVES THEREOF | May 2022 | September 2024 | Allow | 28 | 1 | 1 | Yes | No |
| 17744300 | SYSTEM FOR IMPROVED PRODUCTION TITERS IN FERMENTATIONS | May 2022 | March 2024 | Allow | 22 | 1 | 1 | No | No |
| 17740550 | METHOD OF PRODUCING VALUE-ADDED CHEMICALS BY USING CLOSTRIDIUM AND BACILLUS CO-CULTURES | May 2022 | April 2024 | Allow | 24 | 2 | 1 | No | No |
| 17775649 | MONOMER POLYPEPTIDE HAVING HYDROGENASE ACTIVITY, IN PARTICULAR RECOMBINANT MONOMER POLYPEPTIDE HAVING HYDROGENASE ACTIVITY | May 2022 | January 2026 | Allow | 45 | 2 | 0 | Yes | No |
| 17755266 | TRANSAMINASE MUTANT AND USE THEREOF | April 2022 | August 2025 | Allow | 40 | 1 | 1 | No | No |
| 17717141 | Compositions and methods for converting methanol into hydrogen peroxide and carbon dioxide | April 2022 | August 2025 | Abandon | 40 | 1 | 0 | No | No |
| 17658214 | SYNTHESIS OF BETA-HYDROXYISOVALERATE AND METHODS OF USE | April 2022 | October 2024 | Allow | 30 | 2 | 1 | Yes | No |
| 17711382 | ENGINEERED ADENYLATE KINASE VARIANT ENZYMES | April 2022 | October 2023 | Allow | 18 | 1 | 1 | No | No |
| 17765645 | DNA POLYMERASE AND DNA POLYMERASE DERIVED 3'-5'EXONUCLEASE | March 2022 | December 2025 | Allow | 44 | 2 | 1 | Yes | No |
| 17693349 | RECOMBINANT STRAIN FOR PRODUCING SHIKIMIC ACID, AND CONSTRUCTION METHOD AND USE THEREOF | March 2022 | July 2025 | Allow | 40 | 2 | 0 | Yes | No |
| 17691010 | MICROORGANISMS FOR THE PRODUCTION OF ADIPIC ACID AND OTHER COMPOUNDS | March 2022 | December 2023 | Abandon | 21 | 1 | 0 | No | No |
| 17641358 | TRANSFORMED MICROORGANISM AND METHOD OF PRODUCING POLYHYDROXYALKANOATE USING THE MICROORGANISM | March 2022 | March 2025 | Allow | 36 | 1 | 0 | No | No |
| 17652835 | METHODS OF PRODUCING SUCCINIC ACID FROM A BIOMASS | February 2022 | December 2023 | Allow | 21 | 2 | 0 | No | No |
| 17679855 | BACTERIAL ENGINEERING | February 2022 | July 2023 | Abandon | 16 | 0 | 1 | No | No |
| 17674712 | COMPOSITIONS COMPRISING POLYPEPTIDES HAVING XYLANASE ACTIVITY AND POLYPEPTIDES HAVING ARABINOFURANOSIDASE ACTIVITY | February 2022 | June 2023 | Allow | 16 | 1 | 0 | Yes | No |
| 17665441 | BIOSYNTHESIS OF CANNABINOIDS AND CANNABINOID PRECURSORS | February 2022 | June 2025 | Abandon | 41 | 0 | 1 | No | No |
| 17585527 | TREATMENT OF RETINITIS PIGMENTOSA USING ENGINEERED MEGANUCLEASES | January 2022 | October 2023 | Abandon | 21 | 1 | 1 | No | No |
| 17629485 | METHOD FOR PREPARING BLOCK COPOLYMER | January 2022 | June 2025 | Allow | 40 | 2 | 0 | No | No |
| 17625783 | ESTERASES AND USES THEREOF | January 2022 | February 2025 | Allow | 37 | 1 | 1 | No | No |
| 17619431 | SELECTIVE PROCESS FOR PREPARING SULFOXIDES BY ENZYMATIC CATALYSIS | December 2021 | February 2026 | Abandon | 50 | 3 | 0 | No | No |
| 17545616 | METHOD FOR THE IN VIVO SYNTHESIS OF 4-HYDROXYMETHYLFURFURAL AND DERIVATIVES THEREOF | December 2021 | January 2024 | Allow | 26 | 2 | 0 | No | No |
| 17544026 | Detergent Composition | December 2021 | March 2024 | Allow | 27 | 2 | 0 | Yes | No |
| 17533739 | MODIFIED BETA-LACTAMASES AND METHODS AND USES RELATED THERETO | November 2021 | February 2023 | Allow | 15 | 2 | 0 | Yes | No |
| 17505945 | MACHINE LEARNING GENE MINING METHOD AND PHOSPHINOTHRICIN DEHYDROGENASE MUTANT FOR AMINO TRANSLOCATION | October 2021 | May 2023 | Allow | 19 | 1 | 1 | Yes | No |
| 17603259 | STABILIZED GLYCOSIDE HYDROLASE VARIANTS | October 2021 | January 2026 | Allow | 51 | 2 | 1 | No | No |
| 17471615 | Recombinant Production of Steviol Glycosides | September 2021 | June 2023 | Abandon | 21 | 1 | 0 | No | No |
| 17461102 | METHANE MONOOXYGENASE ENZYMES | August 2021 | August 2023 | Allow | 23 | 1 | 1 | Yes | No |
| 17426569 | SUBTILASE VARIANTS AND COMPOSITIONS COMPRISING SAME | July 2021 | December 2025 | Allow | 52 | 2 | 1 | No | No |
| 17387806 | PROCESS FOR MAKING RECOMBINANT ANTIDOTE TO FACTOR XA INHIBITOR | July 2021 | April 2023 | Abandon | 21 | 1 | 0 | No | No |
| 17375462 | ENGINEERED CAS9 NUCLEASES | July 2021 | October 2024 | Allow | 39 | 2 | 1 | No | No |
| 17354819 | ALPHA (1,2) FUCOSYLTRANSFERASE SYNGENES FOR USE IN THE PRODUCTION OF FUCOSYLATED OLIGOSACCHARIDES | June 2021 | December 2022 | Allow | 18 | 0 | 0 | No | No |
| 17335812 | Production Of Fatty Acid Derivatives | June 2021 | October 2023 | Abandon | 28 | 1 | 1 | No | No |
| 17333141 | RECOMBINANT MUTANT MICROORGANISM AND METHOD FOR PRODUCING CADAVERINE BY USING SAME MICROORGANISM | May 2021 | October 2024 | Abandon | 41 | 4 | 0 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner EPSTEIN, TODD MATTHEW.
With a 40.0% reversal rate, the PTAB reverses the examiner's rejections in a meaningful percentage of cases. This reversal rate is above the USPTO average, indicating that appeals have better success here than typical.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 23.8% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is below the USPTO average, suggesting that filing an appeal has limited effectiveness in prompting favorable reconsideration.
✓ Appeals to PTAB show good success rates. If you have a strong case on the merits, consider fully prosecuting the appeal to a Board decision.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner EPSTEIN, TODD MATTHEW works in Art Unit 1652 and has examined 507 patent applications in our dataset. With an allowance rate of 57.6%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 29 months.
Examiner EPSTEIN, TODD MATTHEW's allowance rate of 57.6% places them in the 18% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by EPSTEIN, TODD MATTHEW receive 2.12 office actions before reaching final disposition. This places the examiner in the 57% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.
The median time to disposition (half-life) for applications examined by EPSTEIN, TODD MATTHEW is 29 months. This places the examiner in the 62% percentile for prosecution speed. Prosecution timelines are slightly faster than average with this examiner.
Conducting an examiner interview provides a +54.2% benefit to allowance rate for applications examined by EPSTEIN, TODD MATTHEW. This interview benefit is in the 95% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 23.6% of applications are subsequently allowed. This success rate is in the 33% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.
This examiner enters after-final amendments leading to allowance in 43.1% of cases where such amendments are filed. This entry rate is in the 66% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.
When applicants request a pre-appeal conference (PAC) with this examiner, 50.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 42% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.
This examiner withdraws rejections or reopens prosecution in 61.5% of appeals filed. This is in the 39% percentile among all examiners. Of these withdrawals, 75.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows below-average willingness to reconsider rejections during appeals. Be prepared to fully prosecute appeals if filed.
When applicants file petitions regarding this examiner's actions, 88.6% are granted (fully or in part). This grant rate is in the 88% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 2% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.7% of allowed cases (in the 57% percentile). This examiner issues Quayle actions more often than average when claims are allowable but formal matters remain (MPEP § 714.14).
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.